• Which meeting are you claiming credit for?*
  • What best describes your title?*
  • If PharmD, please enter your DOB:*
     - -
    2 digit month, 2 digit day, 4 digit year
  • What is the prevalence of endogenous hypercortisolism in patients with resistant hypertension in general, as assessed by dexamethasone suppression test, and in patients with underlying uncontrolled diabetes mellitus?*
  • Mrs. YK is a 47-year-old female patient receiving mifepristone for endogenous hypercortisolism complicated by uncontrolled hyperglycemia. Her HbA1c decreased by 1.4 points from 8.2 to 6.8 and she is responding well to therapy, while being able to cut down the dosing of her oral antidiabetic therapy by 30%. Her BP is 137/87 mm Hg, HR 81. She is on losartan 100 mg daily, hydrochlorothiazide 25 mg daily, amlodipine 5 mg daily for her HTN. Serum Na 141, K 3.3, Bicarbonate 25, BUN 13, Creatinine 0.83. She does report some lower extremity edema. What is the next best step for management of her hypertension?*
  • The following meets diagnostic laboratory criteria for hypercortisolism following a 1 mg (given at 11:00 pm) overnight dexamethasone suppression test:*
  • Each of the following clinical scenarios may prompt one to consider screening for hypercortisolism, except:*
  • Learning Objectives
    Rows
  • Do you feel this activity was fair balanced and free of commercial bias?
  • This educational activity will result in a change in my role as a healthcare team member.
  • This educational activity will result in a change in my practice behavior.
  • Based on your participation in this activity, choose the statement(s) that applies to how your role as a healthcare team member will change:

  • Attestation:

    AcademicCME designates this live material for a maximum of 1.0 AMA PRA Category 1 CreditTM.

    AcademicCME designates this live material for a maximum of 1.0 CNE Contact Hour, including 1.0 Pharmacotherapeutic Contact Hour (Provider #P0491).

    AcademicCME designates this continuing education activity for 1.0 CPE Contact Hour (0.10 CEUs) of Continuing Pharmacy Education Credit (UAN # JA4008190-0000-25-033-H01-P).

    Participants should claim only the credit commensurate with the extent of their participation in the activity.

  • I participated in this activity and claim:*
  • Should be Empty: